XML 59 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Supplementary Information - Quarterly Results of Operations (unaudited)
 12 Months Ended
Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]  
Supplementary Information - Quarterly Results of Operations Unaudited SUPPLEMENTARY INFORMATION - QUARTERLY RESULTS OF OPERATIONS (unaudited)

The following table summarizes our unaudited quarterly financial data for 2018 and 2017 (in thousands, except per share amounts):
 
Quarter Ended
 
 
 
March 31
 
June 30
 
September 30
 
December 31
 
Total
2018
 
 
 
 
 
 
 
 
 
Net sales
$
114,813

 
$
75,498

 
$
91,057

 
$
115,385

 
$
396,753

Gross profit
58,871

 
33,648

 
38,506

 
50,715

 
181,740

Operating income
10,697

 
1,202

 
6,160

 
2,710

 
20,769

Income from continuing operations
8,140

 
1,007

 
4,503

 
1,460

 
15,110

Loss from discontinued operations
(81
)
 
(79
)
 
(194
)
 
(98
)
 
(452
)
Net income
8,059

 
928

 
4,309

 
1,362

 
14,658

Net income per share:
 
 
 
 
 
 
 
 
 
Basic
$
0.27

 
$
0.03

 
$
0.14

 
$
0.05

 
$
0.49

Diluted
0.26

 
0.03

 
0.14

 
0.05

 
0.48

 
 
 
 
 
 
 
 
 
 
2017
 
 
 
 
 
 
 
 
 
Net sales
$
113,252

 
$
77,029

 
$
88,132

 
$
127,771

 
$
406,184

Gross profit
61,745

 
38,378

 
41,315

 
62,444

 
203,882

Operating income(1)
12,683

 
3,849

 
13,365

 
6,406

 
36,303

Income from continuing operations(2)
8,185

 
2,566

 
8,342

 
8,532

 
27,625

Loss from discontinued operations(3)
(1,092
)
 
(77
)
 
(101
)
 
(88
)
 
(1,358
)
Net income
7,093

 
2,489

 
8,241

 
8,444

 
26,267

Net income per share:
 
 
 
 
 
 
 
 
 
Basic
$
0.23

 
$
0.08

 
$
0.27

 
$
0.28

 
$
0.86

Diluted
0.23

 
0.08

 
0.27

 
0.27

 
0.85


(1) Operating income for the quarter ended December 31, 2017 included an $8.8 million non-cash asset impairment charge related to the Octane Fitness brand name.
(2) Income from continuing operations for the quarter ended December 31, 2017 included a non-recurring tax benefit of $5.6 million related to the change in U.S. tax law that resulted in the reassessment of certain deferred tax assets and liabilities.
(3) Loss from discontinued operations for the quarter ended March 31, 2017 included a $1.2 million expense related to a lawsuit settlement with Biosig Instruments, Inc.